Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer (2015)
- Authors:
- Wei, Shuo - Harvard University (HU)
- Kozono, Shingo - Harvard University (HU)
- Kats, Lev - Harvard University (HU)
- Nechama, Morris - Harvard University (HU)
- Li, Wenzong - Harvard University (HU)
- Guarnerio, Jlenia - Harvard University (HU)
- Luo, Manli - Harvard University (HU)
- You, Mi-Hyeon - Harvard University (HU)
- Yao, Yandan - Harvard University (HU)
- Kondo, Asami - Harvard University (HU)
- Hu, Hai - Harvard University (HU)
- Bozkurt, Gunes - Harvard University (HU)
- Moerke, Nathan
- Cao, Shungeng - Harvard University (HU)
- Reschke, Markus - Harvard University (HU)
- Chen, Chun-Hau - Harvard University (HU)
- Rego, Eduardo Magalhães
- Lo-Coco, Francesco - Harvard University (HU)
- Cantley, Lewis C. - Harvard University (HU)
- Lee, Tae Ho - Harvard University (HU)
- Wu, Hao - Harvard University (HU)
- Pandolfi, Pier Paolo - Harvard University (HU)
- Zhou, Xiao Zhen - Harvard University (HU)
- Lu, Kun Ping - Harvard University (HU)
- Autor USP: REGO, EDUARDO MAGALHÃES - FMRP
- Unidade: FMRP
- DOI: 10.1038/nm.3839
- Subjects: LEUCEMIA MIELOIDE AGUDA; FOSFATOS; CATÁLISE
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Nature Medicine
- ISSN: 1078-8956
- Volume/Número/Paginação/Ano: v. 21, n. 5, p. 457-466, 2015
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: unspecified-oa
-
ABNT
WEI, Shuo et al. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer. Nature Medicine, v. 21, n. 5, p. 457-466, 2015Tradução . . Disponível em: https://doi.org/10.1038/nm.3839. Acesso em: 24 abr. 2024. -
APA
Wei, S., Kozono, S., Kats, L., Nechama, M., Li, W., Guarnerio, J., et al. (2015). Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer. Nature Medicine, 21( 5), 457-466. doi:10.1038/nm.3839 -
NLM
Wei S, Kozono S, Kats L, Nechama M, Li W, Guarnerio J, Luo M, You M-H, Yao Y, Kondo A, Hu H, Bozkurt G, Moerke N, Cao S, Reschke M, Chen C-H, Rego EM, Lo-Coco F, Cantley LC, Lee TH, Wu H, Pandolfi PP, Zhou XZ, Lu KP. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer [Internet]. Nature Medicine. 2015 ; 21( 5): 457-466.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1038/nm.3839 -
Vancouver
Wei S, Kozono S, Kats L, Nechama M, Li W, Guarnerio J, Luo M, You M-H, Yao Y, Kondo A, Hu H, Bozkurt G, Moerke N, Cao S, Reschke M, Chen C-H, Rego EM, Lo-Coco F, Cantley LC, Lee TH, Wu H, Pandolfi PP, Zhou XZ, Lu KP. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer [Internet]. Nature Medicine. 2015 ; 21( 5): 457-466.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1038/nm.3839 - Trangenic mice expressing hCG-NuMA-RAR'alfa' develop hematopoietic abnormalities leading to acute promyelocytic leukemia
- Role od promyelocytic leukemia (PML) protein in tumor suppression
- Estudo da relevância da inativação do CCAAT enhancer binding protein 'alfa' (C/EBP'alfa') na gênese da leucemia promielocítica
- Linfomas não Hodgkin de células T maduras e de células NK extramodais
- Identification of myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia
- Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma
- Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia
- Florence: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk
- Anemia e palidez
- Temporal trends in Hematopoietic Stem Cell Transplantation in Argentina. [Editorial]: regional differences that mirror the global reality
Informações sobre o DOI: 10.1038/nm.3839 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
